1-(4-bromophenyl)-2-(4-nitrophenoxy)ethanone, 95.0%, 5g

1-(tert-Butoxycarbonyl)-3-hydroxyazetidine-3-carboxylic acid, 95.0%, 1g

4-(2-Bromo-4-(trifluoromethyl)phenyl)morpholine, 95+%, 1g

1,2-Dichloro-4-methyl-5-(trifluoromethyl)benzene, 98%, 5g

4-(4-Methoxyphenyl)-1-butanol, 98.0%, 500g

tert-butyl (2S)-4,4-difluoro-2-{4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazol-2-yl}pyrrolidine-1-carboxylate, 100mg

5-{[3-(2-hydroxy-6-methoxyphenyl)-1H-pyrazol-5-yl]amino}pyrazine-2-carbonitrile dihydrochloride, 97%, 500mg

Methyl 1-methyl-4-oxopiperidine-3-carboxylate hydrochloride, 95.0%, 5g

3-amino-4,5-dichlorobenzoic acid hydrochloride, 95.0%, 250mg

2-Methoxy-5-methylbenzyl alcohol, 97.0%, 10g

Aminopropyl terminated Polydimethylsiloxane cSt 50-60, 1kg

2-Amino-5-ethyl-1,3,4-thiadiazole, 97.0%, 5g

1-(2-Methoxyethoxy)-4-nitrobenzene, 95.0%, 1g